| Factor Information | |
|---|---|
| Data ID | 1335 |
| Factor | Mean age at implantation |
| Description | N/A |
| Biomarker | NA |
| Classification | E1 (physiological factor - age) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the outcome of ICD according to programming |
| p Value | 0.05 |
| Conclusion | Patients who received an ICD as secondary prevention (mean 37 years) were significantly younger than those receiving primary prevention devices (mean 48 years, P=0.05) |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 519 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/TGA/ASD/PDA/EA/DORV/DCRV/DILV/TA/VSD, RVOTO/PDA, VSD |
| Reference | |
|---|---|
| PMID | 27234868 |
| Year | 2016 |
| Title | Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | N/A | |
| Region | Birmingham, UK | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | undergoing ICD implant | |
| Group | Primary prevention(Treatment) | Secondary prevention(Control) |
| Number | 42 | N/A |
| Age | 45 (21–71) years. | N/A |
| Gender (Male: Female) | 23:19 | N/A |
| Marker Level | 48.3 years | 37 years |
